Culturally, cannabis has successfully rebranded itself as a lifestyle and wellness product. Consumers discuss terpene profiles and regional strains with the same reverence usually reserved for local IPAs and vintage wines. But behind the scenes, the industry is bracing for a massive regulatory shift in the exact opposite direction—one that treats cannabis strictly as a … [Read more...] about From Craft Beer to Aspirin: Why Cannabis is Reverting to Connecticut’s Pharmacy Model

